Noradrenergic Drugs Improve Cognition, Apathy in Alzheimer Disease
Researchers sought to evaluate the efficacy of noradrenergic drugs in the improvement of neuropsychiatric and cognitive symptoms in individuals with AD.
Diagnosis & Disease Information
Identifying Risk Factors for Alzheimer Disease: Are They Modifiable?
Ines Moreno-Gonzalez, PhD, an adjunct associate professor of neurology, explains healthy aging can help reduce lifestyle risk factors for Alzheimer disease.
Gender-Specific Lipid and Hypermetabolism Risk Profiles for Amyotrophic Lateral Sclerosis
In a retrospective study, researchers assessed the predictive value or serum lipid profiles on the basis of gender and hypermetabolism in patients with ALS.
Amyotrophic Lateral Sclerosis Diet: The Tolerability of High-Caloric Food Supplements
Researchers sought to compare various high-caloric food supplements as add-on therapy to normal food intake and standard treatment in patients with ALS.
Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
Higher HDL and Apolipoprotein A1 Levels Tied to Reduced ALS Risk
Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.
Neurodegenerative Disease and COVID-19: Assessing Outcomes in Hospitalized Patients
A team of researchers assessed COVID-19 outcomes in patients with neurodegenerative diseases compared with patients without such disease.
- Loading...
Loading...
Loading... 
Loading...